ABX-1431 Uses, Dosage, Side Effects and more
ABX-1431 is under investigation in clinical trial NCT03625453 (Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder).
| Trade Name | ABX-1431 |
| Generic | ABX-1431 |
| Type | |
| Formula | C20H22F9N3O2 |
| Weight | Average: 507.401 Monoisotopic: 507.156830427 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
